Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 81-100 of 152

Title Anticipated publication date Referral date Process
Lymphoma (non Hodgkin's) - bendamustine (with rituximab) [ID434] TBC Jan 2011 STA
Lymphoma (non Hodgkin's, peripheral T-cell) - pralatrexate [ID368] TBC Sep 2010 STA
Macular oedema (diabetic) - dexamethasone intravitreal implant [ID653] Apr 2015 Feb 2014 STA
Macular oedema (diabetic) - pegaptanib sodium [ID452] TBC Mar 2011 STA
Major depressive disorder - vortioxetine [ID583] May 2015 STA
Melanoma (advanced and metastatic) - temozolomide [ID316] TBC Jun 2008 STA
Melanoma (BRAF V600, unresectable, metastatic) - dabrafenib [ID605] TBC STA
Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib [ID605] TBC STA
Melanoma (metastatic) - paclitaxel albumin-bound nanoparticles (1st line) [ID570] May 2015 Oct 2013 STA
Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74] TBC Nov 2008 STA
Multiple myeloma (newly diagnosed) - lenalidomide [ID474] TBC Jul 2011 STA
Multiple myeloma (one prior therapy) - vorinostat (with bortezomib) [ID501] TBC Nov 2011 STA
Multiple myeloma (relapsed, refractory) - pomalidomide [ID666] Feb 2015 Dec 2013 STA
Multiple myeloma - bortezomib (consolidation therapy) [ID529] TBC May 2012 STA
Multiple myeloma - bortezomib (induction therapy) [ID610] May 2014 May 2012 STA
Multiple myeloma - lenalidomide (maintenance, post autologous stem cell transplantation) [ID475] TBC Jul 2011 STA
Multiple myeloma - lenalidomide (post bortezomib) (part rev TA171) [ID667] Jul 2014 STA
Multiple sclerosis (primary-progressive) - fingolimod [ID62] TBC Nov 2008 STA
Multiple sclerosis (relapsing-remitting) - alemtuzumab [ID539] May 2014 STA
Multiple sclerosis (relapsing-remitting) - dimethyl fumarate [ID585] TBC STA

This page was last updated: 17 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.